Journal
ELIFE
Volume 1, Issue -, Pages -Publisher
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.00205
Keywords
-
Categories
Funding
- Wellcome Trust [WT0834922, WT081385]
- UK Medical Research Council
- Cancer Research UK [C28585/A10839]
- Lister institute of Preventive Medicine
- RIKEN
- Biomedical Research Centre (NIHR), Oxford, UK
- St John's College, Oxford
- MRC [MC_U137761446, MC_EX_G1000902] Funding Source: UKRI
- Medical Research Council [MC_EX_G1000902, MC_U137761446] Funding Source: researchfish
- Grants-in-Aid for Scientific Research [23249015, 20062014] Funding Source: KAKEN
Ask authors/readers for more resources
CpG islands (CGIs) are associated with most mammalian gene promoters. A subset of CGIs act as polycomb response elements (PREs) and are recognized by the polycomb silencing systems to regulate expression of genes involved in early development. How CGIs function mechanistically as nucleation sites for polycomb repressive complexes remains unknown. Here we discover that KDM2B (FBXL10) specifically recognizes non-methylated DNA in CGIs and recruits the polycomb repressive complex 1 (PRC1). This contributes to histone H2A lysine 119 ubiquitylation (H2AK119ub1) and gene repression. Unexpectedly, we also find that CGIs are occupied by low levels of PRC1 throughout the genome, suggesting that the KDM2B-PRC1 complex may sample CGI-associated genes for susceptibility to polycomb-mediated silencing. These observations demonstrate an unexpected and direct link between recognition of CGIs by KDM2B and targeting of the polycomb repressive system. This provides the basis for a new model describing the functionality of CGIs as mammalian PREs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available